SI2590973T1 - Soli solifenacina - Google Patents

Soli solifenacina

Info

Publication number
SI2590973T1
SI2590973T1 SI201130976A SI201130976A SI2590973T1 SI 2590973 T1 SI2590973 T1 SI 2590973T1 SI 201130976 A SI201130976 A SI 201130976A SI 201130976 A SI201130976 A SI 201130976A SI 2590973 T1 SI2590973 T1 SI 2590973T1
Authority
SI
Slovenia
Prior art keywords
solifenacin
salts
solifenacin salts
Prior art date
Application number
SI201130976A
Other languages
English (en)
Inventor
Gerardo Gutierrez Fuentes
Antonio Lorente Bonde-Larsen
Jaime Del Campo Lopez-Bachiller
Celso Sandoval Rodriguez
Yolanda Fernandez Sainz
Original Assignee
Crystal Pharma, S.A.U.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crystal Pharma, S.A.U. filed Critical Crystal Pharma, S.A.U.
Publication of SI2590973T1 publication Critical patent/SI2590973T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
SI201130976A 2010-07-05 2011-07-05 Soli solifenacina SI2590973T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10168415 2010-07-05
US201161472807P 2011-04-07 2011-04-07
PCT/EP2011/061314 WO2012004264A1 (en) 2010-07-05 2011-07-05 Solifenacin salts
EP11728902.5A EP2590973B1 (en) 2010-07-05 2011-07-05 Solifenacin salts

Publications (1)

Publication Number Publication Date
SI2590973T1 true SI2590973T1 (sl) 2017-01-31

Family

ID=44627779

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130976A SI2590973T1 (sl) 2010-07-05 2011-07-05 Soli solifenacina

Country Status (7)

Country Link
US (1) US8765785B2 (sl)
EP (1) EP2590973B1 (sl)
JP (1) JP5826262B2 (sl)
CA (1) CA2804107A1 (sl)
ES (1) ES2596293T3 (sl)
SI (1) SI2590973T1 (sl)
WO (1) WO2012004264A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2778167A1 (en) * 2013-03-11 2014-09-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
EP1714965A4 (en) 2004-02-09 2007-12-19 Astellas Pharma Inc COMPOSITION CONTAINING SOLIFENACINE SUCCINATE
WO2005087231A1 (ja) 2004-03-16 2005-09-22 Astellas Pharma Inc. ソリフェナシン含有組成物
CA2561167C (en) 2004-03-25 2012-09-11 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
CA2591761A1 (en) 2004-12-27 2006-07-06 Astellas Pharma Inc. Stable particulate pharmaceutical composition of solifenacin or salt thereof
WO2008011462A2 (en) 2006-07-19 2008-01-24 Dr. Reddy's Laboratories Ltd. Process for preparing solifenacin and its salts
CZ300692B6 (cs) 2006-12-22 2009-07-15 Zentiva, A. S. Zpusob prípravy solifenacinu
US20100298371A1 (en) 2007-12-04 2010-11-25 Mayank Ghanshyambhai Dave Process for preparing chemically and chirally pure solifenacin base and its salts
WO2009139002A2 (en) 2008-05-12 2009-11-19 Msn Laboratories Limited An improved process for the preparation of solifenacin and its pharmaceutically acceptable salts thereof
EP3067353B1 (en) 2008-07-29 2017-11-22 KRKA, D.D., Novo Mesto A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms

Also Published As

Publication number Publication date
EP2590973B1 (en) 2016-08-31
JP2013530201A (ja) 2013-07-25
US20130203804A1 (en) 2013-08-08
JP5826262B2 (ja) 2015-12-02
US8765785B2 (en) 2014-07-01
WO2012004264A1 (en) 2012-01-12
CA2804107A1 (en) 2012-01-12
ES2596293T3 (es) 2017-01-05
EP2590973A1 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
HK1199840A1 (en) Noribogaine salt ansolvates
HK1203196A1 (en) Substituted benzylpyrazoles
IL229513A0 (en) imidazopyridine compounds
EP2717377A4 (en) DRUMS
EP2782184A4 (en) BATTERY
IL231152B (en) buildings for storage
GB201113558D0 (en) Kraftfahrzeugkarosserie mit strukturverstarkter vorderrahmenanbindung
DK2786756T3 (en) Kombinationsterapi med en topoisomeraseinhibitor
EP2622916A4 (en) POSITIONING
EP2686897A4 (en) BATTERY
GB201304499D0 (en) Carcainium Salts
GB201116180D0 (en) Kraftfahrzeug mit warnsystem
EP3701800C0 (en) USE
ZA201402554B (en) Rotatable joint
EP2725637A4 (en) BATTERY
PL2609093T3 (pl) Związek soli
GB201107560D0 (en) Underwater location
EP2785766A4 (en) HYDROXYPOLYAMINSALZE
EP2690698A4 (en) BATTERY
EP2755264A4 (en) BATTERY
PL2604863T3 (pl) Sprężarka rotacyjna
PL2665867T3 (pl) Tor
GB2484028B (en) Power-scalable betavoltaic battery
PL2388095T3 (pl) Narzędzie do frezowania
SI2590973T1 (sl) Soli solifenacina